Pomegranate

DB14317Investigational

Pomegranate is a plant/plant extract used in some OTC (over-the-counter) products. It is not an approved drug.

Mechanism: Pharmacologically active on Pancreatic triacylglycerol lipase, Dipeptidyl peptidase 4, and Cholinesterase
Curator reviewed
Also known as: Ae-pomegrante · Allergenic Extract- Pomegranate Punica Granatum · Dadima Fruit · Pomegranate Extract · Pomegranate Fruit

Resolves to

Compound

Clinical / RWD

Targets

What you can answer from here — as of July 07, 2026

6Protein targetsEach mapped to UniProt, with action and pharmacological action

Listed above

16Clinical trialsPhase, status and sponsor resolved per trial

6Marketed productsAcross 1 country and 4 labellers

7+ReferencesStructured and connected to the statements they support

Which drugs share a target with Pomegranate, and which of those have an active Phase 3 trial?

Create a free account or log in to explore the full data card.